Among patients who had a bladder tumor confirmed at histopathologic examination, urine DNA was positive for at least one of the tested biomarkers (FGFR3 mutations and promoter hypermethylation events) in 94% of cases. This evidence concerns the gene FGFR3 and urinary bladder neoplasm.